ArticleCurrent oncology (Toronto, Ont.)2022

The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two Centers.

Georgios Gaitanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.